KOLOA, Hawaii — Assessing fellow eye status, age and history of uveitis are helpful ways to determine which patients are most likely to benefit from treatment with FDA-approved drugs for geographic atrophy, according to a speaker.
“What I do stress is looking at the lesion growth of prior photographs. Many of us have an extensive history of photos for a lot of these patients,” Robert L. Avery, MD, said during a presentation at Retina 2025. “If we don’t have that, then I use a careful inspection of the ellipsoid zone (Read more...)